These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 24641799)

  • 1. Clinical response to ustekinumab in familial pityriasis rubra pilaris caused by a novel mutation in CARD14.
    Eytan O; Sarig O; Sprecher E; van Steensel MA
    Br J Dermatol; 2014 Aug; 171(2):420-2. PubMed ID: 24641799
    [No Abstract]   [Full Text] [Related]  

  • 2. CARD14-mutations in pityriasis rubra pilaris and therapeutic response to ustekinumab - a hypothesis.
    Volc-Platzer B
    J Dtsch Dermatol Ges; 2020 Nov; 18(11):1312-1315. PubMed ID: 32881385
    [No Abstract]   [Full Text] [Related]  

  • 3. Beneficial effect of ustekinumab in familial pityriasis rubra pilaris with a new missense mutation in CARD14.
    Lwin SM; Hsu CK; Liu L; Huang HY; Levell NJ; McGrath JA
    Br J Dermatol; 2018 Apr; 178(4):969-972. PubMed ID: 28301045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased epidermal expression and absence of mutations in CARD14 in a series of patients with sporadic pityriasis rubra pilaris.
    Eytan O; Qiaoli L; Nousbeck J; van Steensel MA; Burger B; Hohl D; Taïeb A; Prey S; Bachmann D; Avitan-Hersh E; Jin Chung H; Shemer A; Trau H; Bergman R; Fuchs-Telem D; Warshauer E; Israeli S; Itin PH; Sarig O; Uitto J; Sprecher E
    Br J Dermatol; 2014 May; 170(5):1196-8. PubMed ID: 24359224
    [No Abstract]   [Full Text] [Related]  

  • 5. Familial pityriasis rubra pilaris in a Chinese family caused by a novel mutation in CARD14 gene.
    Wu T; Banerjee S; Deng J; Wu J; Huang H; Zheng H; Pan H; Wang Y; Peng Z; Sun X
    Indian J Dermatol Venereol Leprol; 2020; 86(1):81-84. PubMed ID: 31755479
    [No Abstract]   [Full Text] [Related]  

  • 6. CARD14-associated papulosquamous eruption: A spectrum including features of psoriasis and pityriasis rubra pilaris.
    Craiglow BG; Boyden LM; Hu R; Virtanen M; Su J; Rodriguez G; McCarthy C; Luna P; Larralde M; Humphrey S; Holland KE; Hogeling M; Hidalgo-Matlock B; Ferrari B; Fernandez-Faith E; Drolet B; Cordoro KM; Bowcock AM; Antaya RJ; Ashack K; Ashack RJ; Lifton RP; Milstone LM; Paller AS; Choate KA
    J Am Acad Dermatol; 2018 Sep; 79(3):487-494. PubMed ID: 29477734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of CARD14-negative juvenile Pityriasis rubra pilaris with Ustekinumab.
    Reitmajer M; Forchhammer S; Silber T
    J Eur Acad Dermatol Venereol; 2024 Jun; 38(6):e512-e514. PubMed ID: 38084925
    [No Abstract]   [Full Text] [Related]  

  • 8. CARD14 Glu138 mutation in familial pityriasis rubra pilaris does not warrant differentiation from familial psoriasis.
    Inoue N; Dainichi T; Fujisawa A; Nakano H; Sawamura D; Kabashima K
    J Dermatol; 2016 Feb; 43(2):187-9. PubMed ID: 26130407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Ixekizumab Treatment for Patients With Pityriasis Rubra Pilaris: A Single-Arm Trial.
    Haynes D; Strunck JL; Topham CA; Ortega-Loayza AG; Kent G; Cassidy PB; Hu R; Choate K; Wang Z; Liu Y; Greiling TM
    JAMA Dermatol; 2020 Jun; 156(6):668-675. PubMed ID: 32293641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The beneficial effect of a PDE4 inhibitor in a patient with juvenile-onset intractable pityriasis rubra pilaris without CARD14 mutation.
    Inoue E; Arase N; Hanaoka Y; Tanemura A; Fujimoto M
    Dermatol Ther; 2021 Jan; 34(1):e14714. PubMed ID: 33368948
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of a pathogenic
    Nielsen RM; Gram SB; Bygum A
    BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33431438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic analysis of CARD14 in non-familial pityriasis rubra pilaris: a case series.
    Hong JB; Chen PL; Chen YT; Tsai TF
    Acta Derm Venereol; 2014 Sep; 94(5):587-8. PubMed ID: 24577624
    [No Abstract]   [Full Text] [Related]  

  • 13. Pityriasis Rubra Pilaris Type V as an Autoinflammatory Disease by CARD14 Mutations.
    Takeichi T; Sugiura K; Nomura T; Sakamoto T; Ogawa Y; Oiso N; Futei Y; Fujisaki A; Koizumi A; Aoyama Y; Nakajima K; Hatano Y; Hayashi K; Ishida-Yamamoto A; Fujiwara S; Sano S; Iwatsuki K; Kawada A; Suga Y; Shimizu H; McGrath JA; Akiyama M
    JAMA Dermatol; 2017 Jan; 153(1):66-70. PubMed ID: 27760266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Target-sequence Capture and High Throughput Sequencing Identify a De novo CARD14 Mutation in an Infant with Erythrodermic Pityriasis Rubra Pilaris.
    Has C; Schwieger-Briel A; Schlipf N; Hausser I; Chmel N; Rösler B; Technau K; Jakob T; Zimmer A; Fischer J
    Acta Derm Venereol; 2016 Nov; 96(7):989-990. PubMed ID: 27140437
    [No Abstract]   [Full Text] [Related]  

  • 15. Analysis of CARD14 Polymorphisms in Pityriasis Rubra Pilaris: Activation of NF-κB.
    Li Q; Jin Chung H; Ross N; Keller M; Andrews J; Kingman J; Sarig O; Fuchs-Telem D; Sprecher E; Uitto J
    J Invest Dermatol; 2015 Jul; 135(7):1905-1908. PubMed ID: 25734815
    [No Abstract]   [Full Text] [Related]  

  • 16. The management and genetic background of pityriasis rubra pilaris: a single-centre experience.
    Gál B; Göblös A; Danis J; Farkas K; Sulák A; Varga E; Nagy N; Széll M; Kemény L; Bata-Csörgő Z
    J Eur Acad Dermatol Venereol; 2019 May; 33(5):944-949. PubMed ID: 30697821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial pityriasis rubra pilaris is caused by mutations in CARD14.
    Fuchs-Telem D; Sarig O; van Steensel MA; Isakov O; Israeli S; Nousbeck J; Richard K; Winnepenninckx V; Vernooij M; Shomron N; Uitto J; Fleckman P; Richard G; Sprecher E
    Am J Hum Genet; 2012 Jul; 91(1):163-70. PubMed ID: 22703878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical response of CARD14-associated papulosquamous eruption to an anti-interleukin-17A antibody.
    Klein B; Treudler R; Dumann K; Boldt A; Schumann I; Simon JC; Kunz M
    Br J Dermatol; 2022 Sep; 187(3):419-422. PubMed ID: 35262907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole exome sequencing approach to childhood onset familial erythrodermic psoriasis unravels a novel mutation of CARD14 requiring unusual high doses of ustekinumab.
    Signa S; Campione E; Rusmini M; Chiesa S; Grossi A; Omenetti A; Caorsi R; Viglizzo GM; Galluzzo M; Bianchi L; Talamonti M; Orlandi A; Martini A; Ceccherini I; Gattorno M
    Pediatr Rheumatol Online J; 2019 Jul; 17(1):38. PubMed ID: 31286971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel mutation in a CARD14-associated papulosquamous eruption.
    Li N; Tao J; Zhang J; Liu Z; Yu P
    Pediatr Dermatol; 2023; 40(4):706-709. PubMed ID: 36724903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.